Skip to main content
logo
IDNA Genomics Public Ltd (CYS:IDNA)
Cyprus flag Cyprus · Delayed Price · Currency is EUR
10.00
-1.00 (-9.09%)
At close: Sep 21, 2026

IDNA Genomics Public Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Revenue
0.510.490.480.49
Revenue Growth
3.40%2.95%-3.01%-
Gross Profit
-0.12-0.130.130.32
Operating Income
-2-2.15-1.48-1.2
Net Income
-2.14-2.24-2.52-1.34
Earnings Per Share
-0.78-0.81-0.91-0.49
EPS Growth
----

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Cash & Investments
0.010.010.410.1
Total Debt
2.562.922.713.15
Net Cash (Debt)
-2.56-2.91-2.31-3.05
Net Cash Growth
----
Net Cash Per Share
-0.93-1.05-0.84-1.10

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Operating Cash Flow
-0.94-0.25-2.52-0.01
Capital Expenditures
-0-0-0.01-0
Free Cash Flow
-0.95-0.25-2.53-0.01
Free Cash Flow Growth
----

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Gross Margin
-23.75%-26.36%27.22%65.56%
Operating Margin
-393.06%-436.22%-309.19%-244.23%
Pretax Margin
-644.81%-698.45%-620.21%-271.64%
Profit Margin
-420.44%-454.68%-527.75%-272.77%
FCF Margin
-185.78%-50.83%-528.51%-2.62%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period EndingNov '26 Dec '25 Dec '24 Dec '23
PS Ratio
54.23185.05159.33154.54